Taken together, these data show that CD56bright pbNK cells altered their phenotypes towards CD56bright ihNK cells when cultured together with PVR-expressing human hepatoma cells, by downregulating activating and simultaneously upregulating inhibitory NK cell receptors that bind to PVR. This evidence concerns the gene PVR and hepatocellular carcinoma.